Taxane chemotherapy vs antiandrogen agents as first-line therapy for metastatic castration-resistant prostate cancer

Guru Sonpavde, Ahong Huang, Li Wang, Onur Baser, Raymond Miao

Research output: Contribution to journalArticle

8 Scopus citations

Fingerprint Dive into the research topics of 'Taxane chemotherapy vs antiandrogen agents as first-line therapy for metastatic castration-resistant prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences